Last updated Nov 17, 2026. 239 unique records for (semax OR MEHFPGP OR "Met-Glu-His-Phe-Pro-Gly-Pro"). 2026 is a partial year. Cards on this page are chosen for analogue identity and laboratory methods, not for stroke-therapy or other clinical-outcome papers. This page does not restate nootropic, analgesic, or recovery wording from that literature. Source on PubMed
RC-SMX · Neuropeptide Research
RC-SMX
Neuropeptide Research
Vial: reconstitution solution sold separately. Mist Sprayer: includes 5 mL saline solution.
Key specifications
Catalog facts are taken from the live PEPTIDEA™ listing. Formula and molecular weight are from PubChem. Sequence is omitted here.
- Catalog title
- RC-SMX | Neuropeptide Research
- Research focus
- Neuropeptide Research
- Also described as
- Semax · ACTH(4-10) analogue · Met-Glu-His-Phe-Pro-Gly-Pro
- Format
- Lyophilized research peptide
- Catalog status
- In stock (public listing)
- Presentations
- Vial (reconstitution solution sold separately) and Mist Sprayer (includes 5 mL saline solution)Catalog sizes, not a protocol
- Molecular formula
- C37H51N9O10SPubChem CID 9811102
- Molecular weight
- 813.9PubChem average for CID 9811102
- Receptor context
- Described in the literature as a synthetic analogue of ACTH(4-10)Published identity literature; research context only
- Sequence
- Not reproduced hereSee primary literature / PubChem
- Researcher access
- Sign-in required to view pricing
- PubMed records
- 239 uniqueQuery above, Nov 17, 2026
Catalog notes & use limitations
Research-catalog framing only. This section does not describe effects in people or study outcomes.
Catalog notes
Listed under Neuropeptide Research
RC-SMX appears in the PEPTIDEA™ neuropeptide research collection with RU-SLK, RC-ADX, and related listings.
ACTH-analogue identity; no treatment cards
Cards below concern analogue identity and laboratory models. Stroke-therapy, spinal-injury, and other clinical-outcome papers are omitted on purpose and are not restated here.
Vial and Mist Sprayer presentations
The public listing is a variable product whose attribute is Options (Vial or Mist Sprayer), not a size ladder. The catalog SKU RC-301-10 is consistent with a 10 mg presentation mass, but the picker on this page follows the catalog Options attribute. Presentations are not a protocol.
Use limitations
Research use only
Not for human or veterinary use. Not a drug, not a cosmetic, and not medical advice. Not presented here as a treatment or weight-management product.
No outcome or dosing information
This page does not list administration amounts, schedules, or clinical results. Catalog vial sizes are presentations of the research material, not a protocol.
Confirm details from primary sources
Formula and molecular weight are cited from PubChem when a single compound applies; otherwise see the catalog notes. Sequence is omitted. Read the original papers for laboratory context — results stay in the original publications.
Specifications
Laboratory-catalog and public-chemistry details. Items without a cited source are marked.
| Catalog title | RC-SMX | Neuropeptide Research |
|---|---|
| Category | Neuropeptide Research |
| Associated names | Semax; synthetic ACTH(4-10) analogue; Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP) |
| Format | Lyophilized research peptide |
| Public catalog status | In stock (as of Nov 17, 2026) |
| Catalog presentations | Vial (reconstitution solution sold separately) and Mist Sprayer (includes 5 mL saline solution) — sizes of the research material, not a use protocol |
| Molecular formula | C37H51N9O10S (PubChem CID 9811102, retrieved Nov 17, 2026) |
| Molecular weight | 813.9 (PubChem average for CID 9811102) |
| InChIKey | AFEHBIGDWIGTEH-AQRCPPRCSA-N (PubChem) |
| Receptor context | Published papers describe Semax as a synthetic peptide analogue of adrenocorticotropic hormone fragment ACTH(4-10) (Met-Glu-His-Phe-Pro-Gly-Pro). That is an identity description, not a use claim, and findings from clinical stroke or other treatment papers are not restated on this page. |
| Sequence | Not reproduced on this page. See primary literature and the PubChem record. |
| Pricing | Visible after researcher sign-in |
Research literature
These are Peptidea-written summaries of selected publications, prepared so you can stay on peptidea.net. Each card describes what was studied — the research question, study type, and mechanism or setting. We do not restate results, endpoints, or protocols. Full papers remain with their publishers; a small PubMed source link is included only for citation.
Kolbaev et al.
This paper describes Semax as an ACTH(4-10) analogue and examines intracellular calcium dynamics in rat brain neurons. It is included as analogue-identity and laboratory-model literature, not as a treatment study and not as a study of this catalog vial in people.
Calcium-dynamics measurements and any functional inferences in the paper are not restated on this page.
Tabbì et al.
This paper examined the ACTH(4-10) peptide analogue Semax and its affinity for copper(II) in a coordination-chemistry and cell-toxicity laboratory setting. It is included as chemistry literature for the named analogue.
Binding constants, toxicity-model findings, and any protective wording in the paper are not reproduced here.
Dolotov et al.
This paper describes Semax as an analogue of adrenocorticotropin (4-10) and reports a specific-binding study in rat basal forebrain. It is laboratory biochemical work, not a clinical trial.
Binding results and any protein-level findings in the paper are not restated on this page.
Vyunova et al.
This paper discusses synthetic and natural corticotropins and related laboratory analogues. It is included as class-and-identity context for ACTH-fragment analogues such as Semax, not as a use guide.
Activity comparisons and any applied wording in the paper are not reproduced here.
Original titles are omitted or neutralized when they use clinical-outcome wording. Counts and the optional source links use the query (semax OR MEHFPGP OR "Met-Glu-His-Phe-Pro-Gly-Pro"). Source on PubMed
Storage & handling
General laboratory-catalog guidance for layout purposes. Always follow the vial label and your institution’s written procedures.
- Handle as a lyophilized research material intended for laboratory use only.
- Store according to the conditions printed on the label and in any compound document provided to approved researchers.
- Protect closed vials from moisture and unnecessary temperature swings.
- If reconstitution is performed, use only the laboratory’s own written procedures. This page does not provide volumes, solvents, or working concentrations.
- This material is not for human or veterinary use and is not medical advice.
Research Use Only. Not for human or veterinary use. Not medical advice. PEPTIDEA™ is a trademark of Grey Bug LLC.





